Abstract:Platelets are anucleate cell-fragments derived predominantly from megakaryocytes in the bone marrow and released in the blood circulation, with a normal count of 150 000-40 000 per μl and a lifespan of approximately 10 days in humans. A primary role of platelets is to aid in vascular injury site-specific clot formation to stanch bleeding, termed hemostasis. Platelets render hemostasis by a complex concert of mechanisms involving platelet adhesion, activation and aggregation, coagulation amplification, and clot retraction. Additionally, platelet secretome can influence coagulation kinetics and clot morphology. Therefore, platelet defects and dysfunctions result in bleeding complications. Current treatment for such complications involve prophylactic or emergency transfusion of platelets. However, platelet transfusion logistics constantly suffer from limited donor availability, challenges in portability and storage, high bacterial contamination risks, and very short shelf life (~5 days). To address these issues, an exciting area of research is focusing on the development of microparticle- and nanoparticle-based platelet surrogate technologies that can mimic various hemostatic mechanisms of platelets. On the other hand, aberrant occurrence of the platelet mechanisms lead to the pathological manifestation of thrombosis and thromboinflammation. The treatments for this are focused on inhibiting the mechanisms or resolving the formed clots. Here, platelet-inspired technologies can provide unique platforms for disease-targeted drug delivery to achieve high therapeutic efficacy while avoiding systemic side-effects. This review will provide brief mechanistic insight into the role of platelets in hemostasis, thrombosis and thromboinflammation, and present the current state-of-art in the design of platelet-inspired nanomedicine for applications in these areas.

Theranostic nanoparticles for the management of thrombosis

Nano-Medicine for Thrombosis: A Precise Diagnosis and Treatment Strategy

Nano-Medicine for Thrombosis:A Precise Diagnosis and Treatment Strategy

Nanoparticles for Thrombus Diagnosis and Therapy: Emerging Trends in Thrombus-theranostics

Theranostic nanoparticles with disease-specific administration strategies

Application of nanotechnology in thrombus therapy

Cutting-edge advances in nano/biomedicine: A review on transforming thrombolytic therapy

Nanotechnology combining photoacoustic kinetics and chemical kinetics for thrombosis diagnosis and treatment

Theranostic Nanoparticles for Cancer and Cardiovascular Applications

Plasma‐Derived Nanoclusters for Site‐Specific Multimodality Photo/Magnetic Thrombus Theranostics

Peptide-based targeting: Novel concept for thrombosis diagnosis and treatment

Engineered Nanoparticles: Thrombotic Events in Cancer

Platelet‐inspired nanomedicine in hemostasis thrombosis and thromboinflammation

Gold-iron oxide nanoparticle: A unique multimodal theranostic approach for thrombosis

Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics.

Near-infrared Fluorophores for Thrombosis Diagnosis and Therapy.

Thrombus-Targeting Polymeric Nanocarriers and Their Biomedical Applications in Thrombolytic Therapy

Applications of Novel Microscale and Nanoscale Materials for Theranostics: From Design to Clinical Translation

Mechanisms of thrombosis and research progress on targeted antithrombotic drugs

Shear-, Sound-, and Light-Sensitive Nanoparticles for Thrombolytic Drug Delivery.

Thrombolytic Agents: Nanocarriers in Targeted Release